The 6 analysts offering 12-month price forecasts for Ocular Therapeutix Inc have a median target of 12.50, with a high estimate of 29.00 and a low estimate of 6.50. The median estimate represents a +136.29% increase from the last price of 5.29.
The current consensus among 6 polled investment analysts is to Buy stock in Ocular Therapeutix Inc. This rating has held steady since August, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.23
Reporting Date Nov 09
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.